Moleculin Biotech - 48 Year Dividend Yield History | MBRX

Historical dividend payout and yield for Moleculin Biotech (MBRX) since 1971. The current TTM dividend payout for Moleculin Biotech (MBRX) as of February 21, 2019 is $0.00. The current dividend yield for Moleculin Biotech as of February 21, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.036B $0.000B
Moleculin Biotech, Inc. is a preclinical and clinical-stage pharmaceutical company which focused on the development of anti-cancer drug candidates. The company's lead product candidate is Annamycin, a Phase II clinical stage anthracycline for the treatment of relapsed or refractory acute myeloid leukemia. Moleculin Biotech, Inc. is based in Houston, TX.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.316B 12.97
Gilead Sciences (GILD) United States $86.647B 10.87
Bio-Techne Corp (TECH) United States $7.316B 49.29